Frequent amyloid deposition without significant cognitive impairment among the elderly.
about
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratioAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will playToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseMild cognitive impairment: pathology and mechanisms.Neuropathology of non-Alzheimer degenerative disordersThalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuitThe Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord InjuryAmyloid positron emission tomography and cognitive reserveTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesHow does it STAC up? Revisiting the scaffolding theory of aging and cognitionAging, neurodegenerative disease, and traumatic brain injury: the role of neuroimagingThe relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsAlzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategiesPreclinical Alzheimer disease: identification of cases at risk among cognitively intact older individualsBrain imaging in Alzheimer diseaseThe role of inflammasome in Alzheimer's diseaseAlternative neural circuitry that might be impaired in the development of Alzheimer diseasePredictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [CorrectedDevelopment of positron emission tomography β-amyloid plaque imaging agentsUshering in the study and treatment of preclinical Alzheimer diseaseMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseExisting Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluationAttitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research ResultsMolecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain TissueNeuroimaging in vascular cognitive impairment: a state-of-the-art reviewExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsBeta-amyloid deposition and the aging brainValidation of the Face Name Associative Memory Exam in cognitively normal older individualsAtrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsBiochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's diseaseHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadePET amyloid-beta imaging in preclinical Alzheimer's diseaseAssociation of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old.Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease.Markers of cholesterol transport are associated with amyloid deposition in the brain.Arterial stiffness and β-amyloid progression in nondemented elderly adults.Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.In vivo assessment of amyloid-β deposition in nondemented very elderly subjects
P2860
Q24193707-5AC59903-11B2-4E23-A032-9ACA771B9254Q24298670-7A4DE396-4C03-44F6-A2D9-559DA771FF87Q24594531-30575689-2A3D-496F-B552-94CDFE1262BFQ24595802-922BE255-54F8-491F-BD66-80F7F3BB30E9Q24631255-0392138A-B018-4FD9-8D78-C4A2EDF0B1D5Q24657571-679E6D29-43B0-4B8A-B9E1-C37A0270C1C1Q26748827-3679E5FA-9309-4965-A3E2-68DA0E97555CQ26767879-3E28065B-D41D-48E4-BC73-4894AC193ACCQ26769755-F75B1F4F-3219-454E-8361-84C75AF55362Q26771812-C729D4F1-3E42-4A48-83CA-036A3DCEDD7BQ26827532-69C88078-3951-4522-A34A-00F07A3EF7E4Q26828882-AFC8FEB6-F5E9-41CB-8FEB-6B7F6CA07753Q26830467-C62AD19B-3BDD-4D68-9493-C85D61BC51CBQ26852851-596BE960-ADAD-4BD9-81A9-7EBADEB49D45Q26995405-E778DB04-DF54-49F2-96BB-8E0D6F7B7B81Q26996299-1A819A16-53BD-4D4B-92CA-D011FB4766ACQ26996822-26DF92BF-69F3-4469-81DF-0966E7E85366Q27001223-AAB521CF-BEEF-4978-B154-0251769E8B0DQ27007436-A77DCBFE-9A4B-43D9-9AE1-744C160B54E2Q27012742-31365949-737E-4772-AFF0-F3FFE4AA8DE7Q27014791-5BF8C2E1-38E9-4C37-B54F-DD9BDB3233D0Q27027319-CF4AADC8-5BDE-4025-BBEE-0470786F26B8Q27303745-CC3C0AB4-03A9-4B59-AC30-83C5340D62EDQ27345258-7C4B54FD-82AE-444C-AE8A-B57DDA5F1FD3Q27679935-920192F9-E2F5-4BD4-B596-13DDCC4158FDQ28068195-27EB7886-0687-48CE-BF8B-3283D349B9D6Q28075692-0A6A1715-77DA-43AA-A488-40AC8D475B38Q28264556-226AEBA4-B701-4D2B-92BE-825DAD25582DQ28386196-35879AC1-0953-44C0-A6BA-2233774BF229Q28488143-556CDC55-FE80-4B26-A265-F90F6E115A8EQ28542628-3FDA8DE3-1A00-461C-8582-131530EE627CQ29614407-B9476B5D-4F5B-4839-A3DD-19E00BB42D85Q30040695-6BE423D6-81FF-4392-9F58-E98AE452FB15Q30101023-4C6664AD-9E71-4D7B-A090-296FDE672042Q30303122-6561FE91-6A49-44F6-9F31-A30FE3381977Q30361851-825E751C-E1FB-488B-A8FB-E80D4682A557Q30406139-467B23D6-ADC8-4C2F-9A6A-F544177D9F13Q30409084-47BEAF96-7F54-4B9F-9E20-8D5AE1A112F1Q30409644-22F94A1A-2526-49AE-8794-28FBC97BE1A8Q30412704-D8A74065-4D2C-4665-BDC9-2BDA344CC3A8
P2860
Frequent amyloid deposition without significant cognitive impairment among the elderly.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Frequent amyloid deposition without significant cognitive impairment among the elderly.
@en
Frequent amyloid deposition without significant cognitive impairment among the elderly.
@nl
type
label
Frequent amyloid deposition without significant cognitive impairment among the elderly.
@en
Frequent amyloid deposition without significant cognitive impairment among the elderly.
@nl
prefLabel
Frequent amyloid deposition without significant cognitive impairment among the elderly.
@en
Frequent amyloid deposition without significant cognitive impairment among the elderly.
@nl
P2093
P2860
P1433
P1476
Frequent amyloid deposition without significant cognitive impairment among the elderly.
@en
P2093
Ann D Cohen
Beth E Snitz
Brian J Lopresti
Chester A Mathis
Edythe M Halligan
Jeffrey A James
Judith A Saxton
Julie C Price
Nicholas D Tsopelas
Patricia R Houck
P2860
P304
P356
10.1001/ARCHNEUR.65.11.1509
P577
2008-11-01T00:00:00Z